SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 86 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $148,189 | -99.9% | 87,170 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $151,676,000 | +72.7% | 87,170 | +81.7% | 0.00% | +100.0% |
Q1 2018 | $87,806,000 | +46855.1% | 47,981 | -42.7% | 0.00% | -50.0% |
Q4 2017 | $187,000 | -55.8% | 83,788 | -42.6% | 0.00% | -33.3% |
Q3 2017 | $423,000 | -38.8% | 146,004 | -6.0% | 0.00% | -40.0% |
Q2 2017 | $691,000 | +10.0% | 155,299 | +15.2% | 0.01% | +25.0% |
Q1 2017 | $628,000 | -19.2% | 134,855 | +5.6% | 0.00% | -33.3% |
Q4 2016 | $777,000 | +5.6% | 127,660 | -4.4% | 0.01% | +20.0% |
Q3 2016 | $736,000 | +42.4% | 133,569 | -1.9% | 0.01% | +25.0% |
Q2 2016 | $517,000 | +136.1% | 136,108 | +71.8% | 0.00% | +100.0% |
Q1 2016 | $219,000 | -51.2% | 79,239 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $449,000 | +37.3% | 79,239 | +28.5% | 0.00% | +50.0% |
Q3 2015 | $327,000 | -40.0% | 61,661 | -6.1% | 0.00% | -50.0% |
Q2 2015 | $545,000 | +164.6% | 65,643 | -2.7% | 0.00% | +300.0% |
Q4 2014 | $206,000 | +9.6% | 67,438 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $188,000 | -31.4% | 67,438 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $274,000 | -23.5% | 67,438 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $358,000 | -5.8% | 67,438 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $380,000 | +27.1% | 67,438 | +3.2% | 0.00% | +50.0% |
Q3 2013 | $299,000 | +2.7% | 65,362 | -2.9% | 0.00% | 0.0% |
Q2 2013 | $291,000 | – | 67,326 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|